Co-Authors
This is a "connection" page, showing publications co-authored by Samira Fafi-Kremer and Floriane Gallais.
Connection Strength
2.991
-
Evolution of antibody responses up to 13 months after SARS-CoV-2 infection and risk of reinfection. EBioMedicine. 2021 Sep; 71:103561.
Score: 0.964
-
Intrafamilial Exposure to SARS-CoV-2 Associated with Cellular Immune Response without Seroconversion, France. Emerg Infect Dis. 2021 01; 27(1).
Score: 0.916
-
Sex Differences in the Evolution of Neutralizing Antibodies to Severe Acute Respiratory Syndrome Coronavirus 2. J Infect Dis. 2021 09 17; 224(6):983-988.
Score: 0.242
-
Outbreak of SARS-CoV-2 infection in a long-term care facility after COVID-19 BNT162b2 mRNA vaccination. Clin Microbiol Infect. 2021 10; 27(10):1537-1539.
Score: 0.239
-
In-depth virological assessment of kidney transplant recipients with COVID-19. Am J Transplant. 2020 11; 20(11):3162-3172.
Score: 0.226
-
Evaluation of the performance of SARS-CoV-2 serological tools and their positioning in COVID-19 diagnostic strategies. Diagn Microbiol Infect Dis. 2020 Dec; 98(4):115181.
Score: 0.225
-
Strong antibody response after a first dose of a SARS-CoV-2 mRNA-based vaccine in kidney transplant recipients with a previous history of COVID-19. Am J Transplant. 2021 11; 21(11):3808-3810.
Score: 0.060
-
Refining "Long-COVID" by a Prospective Multimodal Evaluation of Patients with Long-Term Symptoms Attributed to SARS-CoV-2 Infection. Infect Dis Ther. 2021 Sep; 10(3):1747-1763.
Score: 0.060
-
Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization. Nature. 2021 08; 596(7871):276-280.
Score: 0.060